Company Filing History:
Years Active: 2016
Title: Alicia Foucourt: Innovator in Medical Compounds
Introduction
Alicia Foucourt is a prominent inventor based in Canteleu, France. She has made significant contributions to the field of medical research, particularly in the development of compounds that target critical health issues. Her work focuses on innovative solutions for conditions such as Down's syndrome, early Alzheimer's disease, and various cancers.
Latest Patents
Alicia Foucourt holds a patent for DYRK1 inhibitors and their uses. The patent describes novel thiazolo[5,4-f]quinazoline compounds and methods that are beneficial in the amelioration, treatment, or control of Down's syndrome and early Alzheimer's disease. Additionally, her invention addresses the treatment of cancers, especially solid tumors. More specifically, the patent relates to DYRK1A and/or DYRK1B inhibitors and methods for preparing such compounds.
Career Highlights
Alicia is currently associated with Diaxonhit, a company known for its innovative approaches in the medical field. Her work has been instrumental in advancing research and development in therapeutic compounds.
Collaborations
Alicia collaborates with notable colleagues, including Bertrand Leblond and Anne-Sophie Casagrande. Their combined expertise contributes to the success of their projects and the advancement of medical research.
Conclusion
Alicia Foucourt is a trailblazer in the field of medical innovation, with a focus on developing compounds that address significant health challenges. Her contributions are paving the way for new treatments and improving the quality of life for many individuals.